Parkinson Disease < Parkinson Disease (blood) < Parkinson Disease (cerebrospinal fluid)

Facettes :

List of bibliographic references indexed by Parkinson Disease (blood)

Number of relevant bibliographic references: 23.
[0-20] [0 - 20][0 - 23][20-22][20-40]

Ident.	Authors (with country if any)	Title
001049 (2012)	Hélène Pouclet [France] ; Thibaud Lebouvier ; Mathurin Flamant ; Emmanuel Coron ; Michel Neunlist ; Pascal Derkinderen ; Tiphaine Rouaud	[Autonomic nervous system as a source of biomarkers in Parkinson's disease].
002A92 (2006)	Jean-Pierre Wolf [France] ; Malika Bouhaddi [France] ; Francis Louisy [France] ; Andrei Mikehiev [France] ; Laurent Mourot [France] ; Sylvie Cappelle [France] ; Fabrice Vuillier [France] ; Pierre Andre [France] ; Lucien Rumbach [France] ; Jacques Regnard [France]	Side-effects of l-dopa on venous tone in Parkinson's disease : a leg-weighing assessment
002B34 (2006)	Agnes Janoshazi [France] ; Francois Sellal [France] ; Christian Marescaux [France] ; Jean-Marie Danion [France] ; Jean Marie Warter [France] ; Jean De Barry [France]	Alteration of protein kinase C conformation in red blood cells : A potential marker for Alzheimer's disease but not for Parkinson's disease
002B72 (2005)	Nathalie Vaserman [France]	Parkinson's disease and osteoporosis.
002B87 (2005)	L. Salauze [France] ; C. Van Der Velden ; I. Lagroye ; B. Veyret ; M. Geffard	Circulating antibodies to cysteinyl catecholamines in amyotrophic lateral sclerosis and Parkinson's disease patients.
002C67 (2005)	Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]	End‐of‐dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double‐blind study
002E30 (2004)	Nicolas Simon [France] ; Radka Gantcheva ; Bernard Bruguerolle ; François Viallet	The effects of a normal protein diet on levodopa plasma kinetics in advanced Parkinson's disease.
002E36 (2004)	Joana Vitte [France] ; Bernard F. Michel ; Pierre Bongrand ; Jean-Louis Gastaut	Oxidative stress level in circulating neutrophils is linked to neurodegenerative diseases.
003013 (2004)	M. Bouhaddi [France] ; F. Vuillier [France] ; J. O. Forkat [France] ; S. Cappelle [France] ; M. T. Henriet [France] ; L. Rumbach [France] ; J. Regnard [France]	Impaired cardiovascular autonomic control in newly and long-term-treated patients with Parkinson's disease: involvement of L-dopa therapy
003825 (2001)	R.-M. Schimpff [France] ; C. Avard [France] ; G. Fenelon [France] ; A-M Lhiaubet [France] ; L. Tenneze [France] ; M. Vidailhet [France] ; W. Rostene [France]	Increased plasma neurotensin concentrations in patients with Parkinson's disease
003E79 (1999)	G. Mercier [France] ; J. C. Turpin [France] ; G. Lucotte [France]	Variable number tandem repeat dopamine transporter gene polymorphism and Parkinson's disease : no association found
004416 (1997)	L. Derex [France] ; P. Trouillas [France]	Reversible parkinsonism, hypophosphoremia, and hypocalcemia under vitamin D therapy
004682 (1996)	M.-E. Llau [France] ; G. Durrieu [France] ; M.-A. Tran [France] ; J.-M. Senard [France] ; O. Rascol [France] ; J.-L. Montastruc [France]	A study of dopaminergic sensitivity in Parkinson's disease : Comparison in ''de novo'' and levodopa-treated patients
004872 (1995)	P. Allain [France] ; A. Le Bouil [France] ; E. Cordillet [France] ; L. Le Quay [France] ; H. Bagheri [France] ; J. L. Montastruc	Sulfate and cysteine levels in the plasma of patients with Parkinson's disease
004898 (1995)	P. Limousin [France] ; P. Pollak [France] ; J. P. Pfeffen ; C. L. Tournier-Gervason [France] ; R. Dubuis ; J. E. Perret [France]	Acute administration of levodopa-benserazide and tolcapone, a COMT inhibitor, in Parkinson's disease
004A92 (1994)	F. Tison [France] ; N. Fouillet ; P. Henry	Apomorphine increases blood glucose concentrations in Parkinson's disease
004B06 (1993)	W. Camu [France] ; M. Billiard ; M. Baldy-Moulinier	Fasting plasma and CSF amino acid levels in amyotrophic lateral sclerosis: a subtype analysis.
004C61 (1993)	J. M. Senard [France] ; O. Rascol [France] ; G. Durrieu [France] ; M. A. Tran [France] ; M. Berlan [France] ; A. Rascol ; J. L. Montastruc	Effects of Yohimbine on plasma catecholamine levels in orthostatic hypotension related to Pakinson disease or multiple system atrophy
004E55 (1991)	G. Durrieu [France] ; J M Senard ; M A Tran ; A. Rascol ; J L Montastruc	Effects of levodopa and bromocriptine on blood pressure and plasma catecholamines in parkinsonians.
005011 (1990)	G. Durrieu [France] ; J M Senard ; O. Rascol ; M A Tran ; X. Lataste ; A. Rascol ; J L Montastruc	Blood pressure and plasma catecholamines in never-treated parkinsonian patients: effect of a selective D1 agonist (CY 208-243).
005012 (1990)	G. Durrieu [France] ; Y. Rispail ; E. Chatelut ; M. Berlan ; A. Rascol ; J L Montastruc ; P. Montastruc	Beta-adrenergic sensitivity in Parkinson's disease: effect of levodopa treatment.

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Parkinson Disease (blood)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Parkinson Disease (blood)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Parkinson Disease (blood)
}}

---

This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024